| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| BCDA | BCDA | Shares | USD | XNCM |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| BCDA | BCDA | Shares | USD | XNCM |
BioCardia, Inc. is a clinical-stage regenerative medicine company focused on developing novel therapeutics for cardiovascular diseases. The company specializes in proprietary biotherapeutic solutions, including its CardiAMP™ and CardiALLO™ therapies, which utilize marrow-derived cells delivered via its Helix™ transendocardial delivery systems. BioCardia serves patients with significant unmet medical needs in the cardiovascular sector, primarily operating in the United States.
No recent RNS announcements for BCDA across BCDA.
No recent RNS announcements for BCDA across BCDA.